Executive Summary
For CEOs driving growth, CIOs leading digital transformation, and CFOs managing risk and returns, omnichannel marketing is no longer optional—it’s a strategic lever for competitive advantage. In life sciences, seamless engagement across digital and physical channels with healthcare professionals (HCPs), patients, and partners directly impacts differentiation, innovation, and financial performance.
Case in point: a global pharmaceutical firm saw a 30% increase in HCP engagement, while a biotech company achieved a 25%+ ROI uplift through AI-driven personalization. These aren’t isolated wins—they’re evidence that disciplined omnichannel execution delivers measurable value.
Yet, execution is often derailed by fragmented data, legacy systems, regulatory complexity, and cultural inertia. This paper reframes these challenges as strategic risks and opportunities, offering a blueprint for executive action and showcasing Wipro’s proven impact.


